Regular patient/clinician interaction can help increase follow-up cancer screening

August 17, 2012

The line “talk to your doctor,” which appears in so many medical-related advertisements, is apparently right. An analysis of colorectal cancer (CRC) patients who maintained regular contact with their clinicians (doctors, nurses, specialists) indicates those patients are more likely to follow recommendations for detecting cancer recurrence than patients who do not. In fact, researchers found CRC patients were more than twice as likely to adhere to medical follow up procedures if they had regular patient clinician information engagement (PCIE).

The study was conducted by a team of researchers from the Center of Excellence in Cancer Communication Research (CECCR) at the University of Pennsylvania’s Annenberg School for Communication. The research team—doctoral student Andy S.L. Tan; Mihaela Moldovan-Johnson, Ph.D.; doctoral student Sarah Parvanta; Stacy W. Gray, MD; Katrina Armstrong, MD; and Robert C. Hornik, Ph.D.—followed over 300 CRC since 2005. The results of their work currently appear in the journal The Oncologist, the official journal of the Society for Translational Oncology. The article title is “Patient-Clinician Information Engagement Improves Adherence to Colorectal Cancer Surveillance after Curative Treatment: Results from a Longitudinal Study.”

The patients in the study—roughly half male, half female; mostly white (88.5 percent); a mean age of 68; and most (72.5%) indicating concern about cancer recurrence—responded to surveys over the three-year span of the study. All reported whether they had received specific follow up screening tests—two or more office visits, two or more serum carcinoembryonic antigen (CEA) tests, and one colonoscopy. The study tracked how often these procedures were received in comparison to the amount of interaction patients had with their clinicians.

While only 41 percent reported receiving all three surveillance procedures, the researchers did note that patients who had consistent PCIE were 2.8 times more likely to adhere to recommended follow up tests.

In the article the research team acknowledges that several socio-demographic and clinical factors affecting whether or not someone follows advice cannot be modified. These include the patients’ age, income level, race, and severity (stage) of the cancer. However, they note that understanding the impact and effects of PCIE can help health professionals develop pilot interventions to improve adherence through patient active engagement with their clinicians on cancer-related information.

“We recommend that prospective studies be considered to determine if pilot programs encouraging active patient engagement with clinicians about -related information would be beneficial in terms of increasing the proportion of patients receiving post-treatment surveillance testing, and ultimately in improving patient outcomes and survival,” the researchers write in their conclusion.

Explore further: Patient navigators appear to improve colorectal cancer screening rate in ethnically diverse patients

More information: The Oncologist August 2012 doi: 10.1634/theoncologist.2012-0173

Related Stories

Patient navigators appear to improve colorectal cancer screening rate in ethnically diverse patients

May 23, 2011
Among low-income patients who are black or whose primary language is not English, patient navigators may help improve colorectal cancer (CRC) screening rates, according to a report in the May 23 issue of Archives of Internal ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.